Saudi Embassy in South Africa holds G20 reception

Trudi Makhaya (left), economic adviser to South Africa's President Cyril Ramaphosa, was among those who attended the reception hosted by  Saudi Ambassador Sultan Al-Anqari in Pretoria. (right). (SPA photo)
Short Url
Updated 17 October 2020

Saudi Embassy in South Africa holds G20 reception

The Saudi ambassador to South Africa, Sultan Al-Anqari, held a reception on Saturday in the capital, Pretoria, followed by a working lunch on the occasion of the Kingdom’s assumption of the G20 presidency and the approaching G20 Summit in November.

In a speech, Al-Anqari emphasized the Kingdom’s leading role during its presidency of the G20, despite the difficult circumstances imposed by the coronavirus disease pandemic.

He pointed out that the pandemic had not prevented the Kingdom from playing its global role in facing this crisis.

“The Kingdom called for an extraordinary G20 summit, presided over by Saudi Arabia’s King Salman, to coordinate international efforts to reduce the pandemic’s economic, health, and humanitarian impact,” he said.

The reception was attended by a number of prominent political and diplomatic figures, including the economic adviser to President Cyril Ramaphosa, Trudi Makhaya, the executive director of the New Partnership for Africa’s Development, Ibrahim Miyake, senior officials from South Africa’s Ministry of International Relations and Cooperation, and the ambassadors of the G20 member states.


Virus vaccine waiting on Saudi ‘green light’

A man works in a laboratory of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (COVID-19) vaccine, during a government-organized media tour in Beijing, China, September 24, 2020. (REUTERS)
Updated 21 min 4 sec ago

Virus vaccine waiting on Saudi ‘green light’

  • Health Ministry reports 398 new COVID-19 cases, 404 recoveries, 20 deaths

JEDDAH: China’s Sinovac coronavirus vaccine is set to be administered to Saudi patients after passing third stage clinical trials, but remains on hold until approved by the Saudi Food and Drug Authority.

King Abdullah International Medical Research Center (KAIMRC) signed an agreement with China’s Sinovac Biotech to receive a vaccine for COVID-19 to be distributed to about 7,000 health workers.
The vaccine has passed the third stage of trials at the King Abdullah Center for the National Guard.
“So far there have been no health complications or allergic reactions in those who have tried the vaccine, except for a fever or mild migraine, but that is normal when vaccination is administered with any virus,” said Aref Al-Amri, head of the Department of Biomolecules and Cytogenetics at the regional laboratory in Riyadh.

FASTFACTS

The total number of coronavirus cases in KSA reached 346,880.

The total number of recoveries in the Kingdom reached 333,409.

KAIMRC’s vaccine unit was among 10 global bodies chosen to test and evaluate several vaccines as part of an international alliance by the World Health Organization, CEPI and NIBSC.
Meanwhile, Saudi Arabia reported 20 new COVID-19-related deaths on Friday, raising the death toll to 5,383. There were 398 new cases reported in the Kingdom, meaning 346,880 people have contracted the disease. There are 8,088 active cases, 766 of which are in critical condition.
According to the Health Ministry, 53 of the newly recorded cases were in Riyadh, while Makkah recorded 32 and Jeddah 37. The ministry also announced that 404 more patients had recovered from the virus, bringing total recoveries in the Kingdom to 333,409.
There were 56,255 polymerase chain reaction tests conducted in the past day, bringing total test numbers to more than 8 million.